Haleon, GB00BMX86B70

Haleon lifts profit outlook, shares trade near 349 pence

25.06.2026 - 16:49:49 | ad-hoc-news.de

Haleon highlights midterm operating profit growth in the high single digits. Marketscreener also shows a 25 June 2026 update with analyst calls and a 349.00 GBX quote on the London market.

Haleon, GB00BMX86B70
Haleon, GB00BMX86B70

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-25, 16:49.

Haleon (GB00BMX86B70) set a clearer tone on profit growth on Thursday, with Marketscreener citing a midterm operating profit target in the high single digits. The consumer-health group also trades on the London market, where HLN was quoted at 349.00 GBX at 16:41 UTC, according to the same market page.Marketscreener report

What Marketscreener reports

Marketscreener says Haleon is forecasting midterm operating profit growth in the high single-digit range. The same page also lists analyst notes dated 24 June and 18 June, including JPMorgan and Rothschild & Co Redburn.Analyst and news feed

The stock also sits inside a wider analyst frame. MarketBeat lists Haleon as an NYSE-traded ticker under HLN and notes its next earnings date page for 2026, while HL's London quote page shows the share price and market cap data for the UK listing.MarketBeat earnings page

The week on the calendar

Thursday keeps the focus on current market context rather than a future forecast. For Haleon, the relevant anchor is the London quote page and the analyst trail on 24 June, which places the stock inside the Stoxx Europe consumer-health conversation.HL share price page

The market page shows an open at 347.10p, a previous close of 348.00p, a market cap of £30.69 billion and a volume of 7,910,123. The live quote makes Haleon one of the more visible consumer-health names in London trade this afternoon.

Go deeper

All news and analysis on the Haleon shares

The topic page collects live market coverage, analyst notes and background material on Haleon's listing and valuation.

How Haleon makes money

Haleon sells consumer-health products across oral health, pain relief, respiratory care and vitamins. Its portfolio includes brands such as Sensodyne, Voltaren, Advil, Panadol and Centrum.Company profile

Haleon on the London market

The Haleon shares (GB00BMX86B70) trade on 2026-06-25, 16:41 on the London market at 349.00 GBX.

Key data on the Haleon shares

  • Company: Haleon plc
  • ISIN: GB00BMX86B70
  • Ticker: HLN
  • Trading venue: London market
  • Price (as of 2026-06-25, 16:41): 349.00 GBX
  • Market cap: £30.69 billion
  • Sector / industry: Consumer healthcare
  • Next earnings date: not officially scheduled

More on the Haleon shares in social media

Disclaimer: This article is for information only and does not constitute investment advice.

en | GB00BMX86B70 | HALEON | boerse | 69624936 | bgmi